{
    "xml": "<topic id=\"PHP4743\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/nafarelin\" basename=\"nafarelin\" title=\"NAFARELIN\">\n<title>NAFARELIN</title>\n<body>\n<data name=\"vtmid\">126196000</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_306177917\" title=\"Gonadotrophin-releasing hormone analogues\">Gonadotrophin-releasing hormone analogues</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n</body>\n<topic id=\"PHP73775\" outputclass=\"drugAction\" rev=\"1.8\" parent=\"/drugs/nafarelin\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>Administration of <b>gonadorelin analogues</b> produces an initial phase of stimulation; continued administration is followed by down-regulation of gonadotrophin-releasing hormone receptors, thereby reducing the release of gonadotrophins (follicle stimulating hormone and luteinising hormone) which in turn leads to inhibition of androgen and oestrogen production.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73753\" outputclass=\"indicationsAndDose\" rev=\"1.16\" parent=\"/drugs/nafarelin\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Endometriosis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intranasal administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult female\">\n<p>Adult (female)</p>\n<p>200&#8239;micrograms twice daily for maximum 6 months (do not repeat), one spray in one nostril in the morning, and one spray in the other nostril in the evening (starting on days 2&#8211;4 of menstruation).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Pituitary desensitisation before induction of ovulation by gonadotrophins for in vitro fertilisation (under expert supervision)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intranasal administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>400&#8239;micrograms twice daily, one spray in each nostril, to be started in early follicular phase (day 2) or, after exclusion of pregnancy, in midluteal phase (day 21) and continued until down regulation achieved (usually within 4 weeks) then maintained (usually for 8&#8211;12 days) during gonadotrophin administration (stopping gonadotrophin and nafarelin on administration of chorionic gonadotrophin at follicular maturity), discontinue if down-regulation not achieved within 12 weeks.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73781\" outputclass=\"contraindications\" rev=\"1.8\" parent=\"/drugs/nafarelin\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<p>\n<ph outputclass=\"contraindication\">Undiagnosed vaginal bleeding</ph>; <ph outputclass=\"contraindication\">use longer than 6 months in the treatment of endometriosis (do not repeat)</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73793\" outputclass=\"cautions\" rev=\"1.8\" parent=\"/drugs/nafarelin\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Patients with metabolic bone disease (decrease in bone mineral density can occur)</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73709\" outputclass=\"sideEffects\" rev=\"1.20\" parent=\"/drugs/nafarelin\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Acne</ph>; <ph outputclass=\"sideEffect\">anaphylaxis</ph>; <ph outputclass=\"sideEffect\">asthma</ph>; <ph outputclass=\"sideEffect\">changes in breast size</ph>; <ph outputclass=\"sideEffect\">changes in scalp and body hair</ph>; <ph outputclass=\"sideEffect\">decrease in trabecular bone density</ph>; <ph outputclass=\"sideEffect\">depression</ph>; <ph outputclass=\"sideEffect\">dyspareunia</ph>; <ph outputclass=\"sideEffect\">headache</ph>; <ph outputclass=\"sideEffect\">hot flushes</ph>; <ph outputclass=\"sideEffect\">hypersensitivity reactions</ph>; <ph outputclass=\"sideEffect\">hypertension</ph>; <ph outputclass=\"sideEffect\">increased sweating</ph>; <ph outputclass=\"sideEffect\">irritation of the nasal mucosa</ph>; <ph outputclass=\"sideEffect\">loss of libido</ph>; <ph outputclass=\"sideEffect\">menopausal-like symptoms</ph>; <ph outputclass=\"sideEffect\">migraine</ph>; <ph outputclass=\"sideEffect\">mood changes</ph>; <ph outputclass=\"sideEffect\">musculoskeletal pain</ph>; <ph outputclass=\"sideEffect\">musculoskeletal weakness</ph>; <ph outputclass=\"sideEffect\">oedema of the face and extremities</ph>; <ph outputclass=\"sideEffect\">ovarian cysts (may require withdrawal)</ph>; <ph outputclass=\"sideEffect\">palpitation</ph>; <ph outputclass=\"sideEffect\">paraesthesia</ph>; <ph outputclass=\"sideEffect\">pruritus</ph>; <ph outputclass=\"sideEffect\">rash</ph>; <ph outputclass=\"sideEffect\">urticaria</ph>; <ph outputclass=\"sideEffect\">vaginal dryness</ph>; <ph outputclass=\"sideEffect\">visual disturbances</ph>; <ph outputclass=\"sideEffect\">weight changes</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Menopausal-like symptoms</p>\n<p>These effects can be reduced by hormone replacement (e.g. with an oestrogen and a progestogen or with tibolone).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73787\" outputclass=\"conceptionAndContraception\" parent=\"/drugs/nafarelin\">\n<title>Conception and contraception</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Non-hormonal, barrier methods of contraception should be used during entire treatment period. Pregnancy should be excluded before treatment, the first dose should be given during menstruation or shortly afterwards or use barrier contraception for 1 month beforehand.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73741\" outputclass=\"pregnancy\" parent=\"/drugs/nafarelin\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73796\" outputclass=\"breastFeeding\" parent=\"/drugs/nafarelin\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73805\" outputclass=\"directionsForAdministration\" rev=\"1.12\" parent=\"/drugs/nafarelin\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>Avoid use of nasal decongestants before and for at least 30 minutes after treatment; repeat dose if sneezing occurs during or immediately after administration.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP73735\" outputclass=\"patientAndCarerAdvice\" rev=\"1.14\" parent=\"/drugs/nafarelin\">\n<title>Patient and carer advice</title>\n<body>\n<section outputclass=\"generalPatientAdvice\">\n<sectiondiv>\n<p>Patients or carers should be given advice on how to administer nafarelin nasal spray.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP4743-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/nafarelin\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74809\" title=\"Spray\" namespace=\"/drugs/nafarelin/spray\">Spray</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP74809\" namespace=\"/drugs/nafarelin/spray\" title=\"Spray\" count=\"1\" rel=\"link\">Spray</xref>\n</links>\n</topic>",
    "id": "PHP4743",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/nafarelin",
    "basename": "nafarelin",
    "title": "NAFARELIN",
    "vtmid": "126196000",
    "drugClassification": [
        "Gonadotrophin-releasing hormone analogues"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Administration of gonadorelin analogues produces an initial phase of stimulation; continued administration is followed by down-regulation of gonadotrophin-releasing hormone receptors, thereby reducing the release of gonadotrophins (follicle stimulating hormone and luteinising hormone) which in turn leads to inhibition of androgen and oestrogen production.",
                "html": "<p>Administration of <b>gonadorelin analogues</b> produces an initial phase of stimulation; continued administration is followed by down-regulation of gonadotrophin-releasing hormone receptors, thereby reducing the release of gonadotrophins (follicle stimulating hormone and luteinising hormone) which in turn leads to inhibition of androgen and oestrogen production.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Endometriosis",
                        "html": "Endometriosis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intranasal administration"
                    ],
                    "textContent": "By intranasal administration",
                    "html": "By intranasal administration"
                },
                "adult female": [
                    {
                        "textContent": "200 micrograms twice daily for maximum 6 months (do not repeat), one spray in one nostril in the morning, and one spray in the other nostril in the evening (starting on days 2&#8211;4 of menstruation).",
                        "html": "<p>200&#8239;micrograms twice daily for maximum 6 months (do not repeat), one spray in one nostril in the morning, and one spray in the other nostril in the evening (starting on days 2&#8211;4 of menstruation).</p>",
                        "ageGroup": "adult (female)"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Pituitary desensitisation before induction of ovulation by gonadotrophins for in vitro fertilisation (under expert supervision)",
                        "html": "Pituitary desensitisation before induction of ovulation by gonadotrophins for in vitro fertilisation (under expert supervision)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intranasal administration"
                    ],
                    "textContent": "By intranasal administration",
                    "html": "By intranasal administration"
                },
                "adult": [
                    {
                        "textContent": "400 micrograms twice daily, one spray in each nostril, to be started in early follicular phase (day 2) or, after exclusion of pregnancy, in midluteal phase (day 21) and continued until down regulation achieved (usually within 4 weeks) then maintained (usually for 8&#8211;12 days) during gonadotrophin administration (stopping gonadotrophin and nafarelin on administration of chorionic gonadotrophin at follicular maturity), discontinue if down-regulation not achieved within 12 weeks.",
                        "html": "<p>400&#8239;micrograms twice daily, one spray in each nostril, to be started in early follicular phase (day 2) or, after exclusion of pregnancy, in midluteal phase (day 21) and continued until down regulation achieved (usually within 4 weeks) then maintained (usually for 8&#8211;12 days) during gonadotrophin administration (stopping gonadotrophin and nafarelin on administration of chorionic gonadotrophin at follicular maturity), discontinue if down-regulation not achieved within 12 weeks.</p>"
                    }
                ]
            }
        ]
    },
    "contraindications": {
        "contraindications": [
            {
                "type": "contraindications",
                "textContent": "Undiagnosed vaginal bleeding",
                "html": "Undiagnosed vaginal bleeding"
            },
            {
                "type": "contraindications",
                "textContent": "use longer than 6 months in the treatment of endometriosis (do not repeat)",
                "html": "use longer than 6 months in the treatment of endometriosis (do not repeat)"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Patients with metabolic bone disease (decrease in bone mineral density can occur)",
                "html": "Patients with metabolic bone disease (decrease in bone mineral density can occur)"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Acne",
                        "html": "Acne",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "anaphylaxis",
                        "html": "anaphylaxis",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "asthma",
                        "html": "asthma",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "changes in breast size",
                        "html": "changes in breast size",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "changes in scalp and body hair",
                        "html": "changes in scalp and body hair",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "decrease in trabecular bone density",
                        "html": "decrease in trabecular bone density",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "depression",
                        "html": "depression",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dyspareunia",
                        "html": "dyspareunia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "headache",
                        "html": "headache",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hot flushes",
                        "html": "hot flushes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypersensitivity reactions",
                        "html": "hypersensitivity reactions",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypertension",
                        "html": "hypertension",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "increased sweating",
                        "html": "increased sweating",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "irritation of the nasal mucosa",
                        "html": "irritation of the nasal mucosa",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "loss of libido",
                        "html": "loss of libido",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "menopausal-like symptoms",
                        "html": "menopausal-like symptoms",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "migraine",
                        "html": "migraine",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "mood changes",
                        "html": "mood changes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "musculoskeletal pain",
                        "html": "musculoskeletal pain",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "musculoskeletal weakness",
                        "html": "musculoskeletal weakness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "oedema of the face and extremities",
                        "html": "oedema of the face and extremities",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "ovarian cysts (may require withdrawal)",
                        "html": "ovarian cysts (may require withdrawal)",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "palpitation",
                        "html": "palpitation",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "paraesthesia",
                        "html": "paraesthesia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "pruritus",
                        "html": "pruritus",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "rash",
                        "html": "rash",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "urticaria",
                        "html": "urticaria",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vaginal dryness",
                        "html": "vaginal dryness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "visual disturbances",
                        "html": "visual disturbances",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "weight changes",
                        "html": "weight changes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Menopausal-like symptoms",
                "textContent": "These effects can be reduced by hormone replacement (e.g. with an oestrogen and a progestogen or with tibolone).",
                "html": "<p>These effects can be reduced by hormone replacement (e.g. with an oestrogen and a progestogen or with tibolone).</p>"
            }
        ]
    },
    "conceptionAndContraception": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Non-hormonal, barrier methods of contraception should be used during entire treatment period. Pregnancy should be excluded before treatment, the first dose should be given during menstruation or shortly afterwards or use barrier contraception for 1 month beforehand.",
                "html": "<p>Non-hormonal, barrier methods of contraception should be used during entire treatment period. Pregnancy should be excluded before treatment, the first dose should be given during menstruation or shortly afterwards or use barrier contraception for 1 month beforehand.</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid.",
                "html": "<p>Avoid.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid.",
                "html": "<p>Avoid.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "Avoid use of nasal decongestants before and for at least 30 minutes after treatment; repeat dose if sneezing occurs during or immediately after administration.",
                "html": "<p>Avoid use of nasal decongestants before and for at least 30 minutes after treatment; repeat dose if sneezing occurs during or immediately after administration.</p>"
            }
        ]
    },
    "patientAndCarerAdvice": {
        "generalPatientAdvice": [
            {
                "type": "generalPatientAdvice",
                "textContent": "Patients or carers should be given advice on how to administer nafarelin nasal spray.",
                "html": "<p>Patients or carers should be given advice on how to administer nafarelin nasal spray.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP74809",
                "label": "Spray",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP74809",
                "label": "Spray",
                "type": "medicinalForm"
            }
        ]
    }
}